Conmed/CNMD

$74.58

-1.95%
-
1D1W1MYTD1YMAX

About Conmed

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Ticker

CNMD

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Curt Hartman

Employees

4,000

Headquarters

Largo, United States

Conmed Metrics

BasicAdvanced
$2.3B
Market cap
36.54
P/E ratio
$2.04
EPS
1.35
Beta
$0.80
Dividend rate
1.07%
Dividend yield
$2.3B
1.34818
$138.47
$73.88
565.62K
$0.80
1.981
0.957
116.652
116.737
38.1%
34.978
3.03%
2.8%
8.16%
3.23%
36.54
1.845
2.75
28.069
0.71%
1.07%
1.07%
19.06%
173.22%
13.01%
84.94%

What the Analysts think about Conmed

Analyst Ratings

Majority rating from 8 analysts.
Buy

Price Targets

Average projection from 7 analysts.
48.26% upside
High $132.00
Low $98.00
$74.58
Current price
$110.57
Average price target

Conmed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.09% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$327M
7.39%
Net income
$33M
108.86%
Profit margin
10.09%
94.79%

Conmed Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 4.5%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.66
$0.83
$0.90
$1.06
-
Expected
$0.60
$0.79
$0.83
$1.11
$0.74
Surprise
10.34%
4.49%
8.43%
-4.5%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Conmed stock?

Conmed (CNMD) has a market cap of $2.3B as of April 15, 2024.

What is the P/E ratio for Conmed stock?

The price to earnings (P/E) ratio for Conmed (CNMD) stock is 36.54 as of April 15, 2024.

Does Conmed stock pay dividends?

Yes, the Conmed (CNMD) stock pays dividends to shareholders. As of April 15, 2024, the dividend rate is $0.8 and the yield is 1.07%. Conmed has a payout ratio of 38.1% on a trailing twelve-month basis.

When is the next Conmed dividend payment date?

The next Conmed (CNMD) dividend payment date is unconfirmed.

What is the beta indicator for Conmed?

Conmed (CNMD) has a beta rating of 1.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Conmed stock price target?

The target price for Conmed (CNMD) stock is $110.57, which is 48.26% above the current price of $74.58. This is an average based on projections from 7 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Conmed stock

Buy or sell Conmed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing